E-support for Healthcare Processes - ASTHMA (E-ASTHMA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01461642|
Recruitment Status : Unknown
Verified October 2011 by Stanislav Šuškovič, The University Clinic of Pulmonary and Allergic Diseases Golnik.
Recruitment status was: Recruiting
First Posted : October 28, 2011
Last Update Posted : October 28, 2011
|Condition or disease||Intervention/treatment||Phase|
|Asthma||Other: Self management asthma plan indorsment.||Not Applicable|
A mobile environment to improve the process of an integrated treatment of people with asthma will be identified, developed, introduced and clinically evaluated. The study will include 120 patients diagnosed with asthma that is poorly managed. The study will use the ACT (Asthma Control Test) questionnaire and an evaluation questionnaire that will cover issues regarding the satisfaction of subjects with asthma care offered. Subjects with a PEF meter, will be able to enter the value of PEF (Peak Expiratory Flow).
In addition to this, users can enter values (1) physical activity (type, duration, intensity), and (2) food (type, quantity).
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||E-support for Healthcare Processes - ASTHMA|
|Study Start Date :||October 2011|
|Estimated Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||April 2013|
|Experimental: Asthma - ICT support.||
Other: Self management asthma plan indorsment.
Subjects adherence to asthma self management plan will be monitored through web-based support.
|No Intervention: Asthma, comparator - no ICT support|
- Number of exacerbations. [ Time Frame: 1 year ]Number of exacerbations per year.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01461642
|Contact: Stanislav Šuškovič, MD, PhD, Prof.||+386 4 2569 firstname.lastname@example.org|
|Contact: Iztok Cukjati||+386 40 186 email@example.com|
|University Clinic of Pulmonary and Allergic Disease||Recruiting|
|Golnik, Slovenia, 4204|
|Contact: Stanislav Šuškovič, MD, PhD, Prof. +386 4 2569 390 firstname.lastname@example.org|
|Contact: Jana Bogataj +386 4 2569 500 email@example.com|
|Sub-Investigator: Sabina Škrgat Kristan, MD, PhD|
|Sub-Investigator: Mateja Marc Malovrh, MD, PhD|
|Sub-Investigator: Matjaž Fležar, MD PhD Doc|
|Sub-Investigator: Mihaela Zidarn, MD, MSci|